VIRGIN GALACTIC HOLDINGS INC (SPCE)

US92766K1060 - Common Stock

0.9273  +0.06 (+6.57%)

Premarket: 0.972 +0.04 (+4.82%)

Fundamental Rating

3

SPCE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 63 industry peers in the Aerospace & Defense industry. SPCE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SPCE is valued quite expensively, but it does show have an excellent growth rating.



0

1. Profitability

1.1 Basic Checks

In the past year SPCE has reported negative net income.
SPCE had a negative operating cash flow in the past year.
SPCE had negative earnings in each of the past 5 years.
SPCE had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

SPCE has a Return On Assets of -42.59%. This is in the lower half of the industry: SPCE underperforms 74.60% of its industry peers.
SPCE's Return On Equity of -99.38% is on the low side compared to the rest of the industry. SPCE is outperformed by 69.84% of its industry peers.
Industry RankSector Rank
ROA -42.59%
ROE -99.38%
ROIC N/A
ROA(3y)-39.83%
ROA(5y)-47.04%
ROE(3y)-81%
ROE(5y)-85.6%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SPCE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

SPCE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SPCE has been increased compared to 1 year ago.
SPCE has more shares outstanding than it did 5 years ago.
SPCE has a better debt/assets ratio than last year.

2.2 Solvency

SPCE has an Altman-Z score of -2.88. This is a bad value and indicates that SPCE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -2.88, SPCE is doing worse than 76.19% of the companies in the same industry.
SPCE has a Debt/Equity ratio of 0.83. This is a neutral value indicating SPCE is somewhat dependend on debt financing.
SPCE has a Debt to Equity ratio of 0.83. This is in the lower half of the industry: SPCE underperforms 69.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF N/A
Altman-Z -2.88
ROIC/WACCN/A
WACC7.8%

2.3 Liquidity

SPCE has a Current Ratio of 5.12. This indicates that SPCE is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SPCE (5.12) is better than 96.83% of its industry peers.
SPCE has a Quick Ratio of 5.03. This indicates that SPCE is financially healthy and has no problem in meeting its short term obligations.
SPCE has a Quick ratio of 5.03. This is amongst the best in the industry. SPCE outperforms 98.41% of its industry peers.
Industry RankSector Rank
Current Ratio 5.12
Quick Ratio 5.03

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.93% over the past year.
SPCE shows a strong growth in Revenue. In the last year, the Revenue has grown by 193.06%.
SPCE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 204.86% yearly.
EPS 1Y (TTM)16.93%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q52.73%
Revenue 1Y (TTM)193.06%
Revenue growth 3Y204.86%
Revenue growth 5YN/A
Revenue growth Q2Q222.87%

3.2 Future

SPCE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.05% yearly.
Based on estimates for the next years, SPCE will show a very strong growth in Revenue. The Revenue will grow by 184.90% on average per year.
EPS Next Y36.09%
EPS Next 2Y23.29%
EPS Next 3Y19.56%
EPS Next 5Y20.05%
Revenue Next Year-25.03%
Revenue Next 2Y-31.13%
Revenue Next 3Y158.61%
Revenue Next 5Y184.9%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SPCE. In the last year negative earnings were reported.
Also next year SPCE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as SPCE's earnings are expected to grow with 19.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.29%
EPS Next 3Y19.56%

0

5. Dividend

5.1 Amount

SPCE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VIRGIN GALACTIC HOLDINGS INC

NYSE:SPCE (5/1/2024, 7:23:16 PM)

Premarket: 0.972 +0.04 (+4.82%)

0.9273

+0.06 (+6.57%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap370.96M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -42.59%
ROE -99.38%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 5.12
Quick Ratio 5.03
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)16.93%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y36.09%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)193.06%
Revenue growth 3Y204.86%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y